Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deals and Financings

Set Alert for Deals

Boston Scientific Expects Up To $40M Impact In Q1 From Coronavirus Outbreak; 10%-12% Revenue Increase For 2020

Boston Scientific said in an earnings call it expects the coronavirus outbreak may lead to a $10m to $40m loss in first-quarter sales as a result of lower procedures volumes and disrupted supply chains in China. For the fourth quarter, Boston Scientific reported $2.9bn in sales.

Sales & Earnings Companies Neurology

Latest From Deals

LSX 2020: Medtronic, J&J And Olympus Map Their M&A Outlook

At the LSX World Congress in London, leaders from Medtronic, Johnson & Johnson and Olympus discussed the evolving medtech mergers and acquisitions landscape, the big opportunity in robotic surgery and the impacts on innovation of the forthcoming EU Medical Device Regulation.

M & A Deals

Report: Securities Lawsuits Against Life Sciences Firms Still On The Rise

More investor suits were brought against life sciences companies in 2019 than in any of the past five years, according to a new report from law firm Dechert LLP. The increase continues a trend that has seen the number of such suits more than double since 2014.

Legal Issues Deals

Medtech 2020 Outlook: Data Reigns Supreme For Device Investors

2019 was a robust year for device fundraising and the trend will continue this year according to Nooman Haque, managing director of life sciences and healthcare at Silicon Valley Bank’s UK branch. However, medtech companies without a data proposition may find themselves struggling to compete.

M & A Deals

Smith & Nephew Boosts ENT Portfolio, Acquires Tusker Medical

Smith & Nephew has acquired Tusker Medical for an undisclosed price. The acquisition comes just months after Tusker’s Tula system was approved by the FDA as a breakthrough device.

Ear Ear, Nose & Throat

QUOTED. 10 January 2020. Francis deSouza.

Illumina Inc. has agreed to pay $98m to terminate its merger agreement with Pacific Biosciences of California Inc. following opposition from antitrust regulators in the US and UK. See what Illumina CEO Francis deSouza said about it here.

Quoted Deals

Illumina Pays Pacific Biosciences $98M To Terminate $1.2Bn Merger Deal

Illumina had planned to acquire Pacific Biosciences to add the company's “long-read” gene sequencing systems to Illumina's own range of "short-read" technologies. However, the UK’s Competition and Markets Authority and the US Federal Trade Commission concluded that the deal would significantly reduce competition in the DNA sequencing market.

Deals M & A

Laborie Bolsters Obstetrics Portfolio With Clinical Innovations Buy

Laborie Medical Technologies has inked a $525m deal to buy obstetrics device maker Clinical Innovations. The acquisition adds a suite of neonatal and fetal care devices to Laborie’s existing obstetrics portfolio.

M & A Deals

J&J Takes Full Ownership Of Verb Surgical, Verily Breaks Off Robotics Partnership

Johnson & Johnson is acquiring the remaining stake in Verb Surgical from Verily following a four-year partnership. The transaction is expected to close in the first half of 2020.

Deals Commercial

FujiFilm Strengthens Position By Adding Hitachi’s Diagnostic Imaging Unit

FujiFilm has signed an agreement to to buy Hitachi’s Diagnostic Imaging Business for $1.63bn to position itself among the top diagnostic imaging heavyweights.

M & A Deals
See All
UsernamePublicRestriction

Register